Hologic to Take Over Cytyc, Forging New Women's Health Giant

and Cytyc Corp. have announced a definitive merger agreement. The cash and stock transaction valued at US$6.2 Billion, is expected to be consummated in the third quarter of 2007.

The new company will be called Hologic and upon closing Cytyc will become a wholly owned subsidiary. Hologic will be one of the largest companies in the world focused exclusively on advanced technology in women's health, and will have a product portfolio that encompasses some of the largest healthcare brands, such as ThinPrep, Lorad, NovaSure, Suros ATEC, Discovery, FullTerm, R2, and MammoSite.

The combined company will have direct operations in over 20 countries with more than 3,300 employees, including 1,200 sales and service professionals. "Both Hologic and Cytyc provide some of the most advanced technology addressing women's health needs,” said Jack Cumming, Hologic's chairman and chief executive officer. By combining our companies' complementary, best-in-class products and technologies, we expect to drive enhanced growth and value creation, and to realize the benefits of this combination quickly and efficiently.”

The combined company will be uniquely positioned to offer a product range that meets many of a woman's screening and treatment needs throughout her life. This range of systems will include integrated systems in screening, diagnostics, and therapeutics for women's health, including, breast cancer, cervical cancer, menorrhagia, pre-natal health, osteoporosis, endometriosis, and permanent contraception.

The merged company is expected to benefit from a broader global platform with direct operations in over 20 countries. Today, approximately 15% of Hologic's and Cytyc's combined revenues are generated internationally. The companies expect to increase growth in international revenues by capitalizing on the increased scope and scale created by this transaction, which will include an international direct sales and service team of over 200 associates and 150 distribution partners supporting sales in over 125 countries. For Hologic's fiscal year 2008, combined revenues are expected to be in excess of $1.7 billion.

Hologic (Bedford, MA, USA) is a leading developer, manufacturer, and supplier of premium diagnostic and medical imaging systems dedicated to serving the healthcare needs of women, and a leading developer of innovative imaging technology for digital radiography and breast imaging. Hologic's core business units are focused on mammography and breast biopsy, osteoporosis assessment, and mini C-arm and extremity MRI imaging for orthopedic applications.

Cytyc (Marlborough, MA, USA) is a diversified diagnostic and medical device company that designs, develops, manufactures, and markets innovative and clinically effective diagnostic and surgical products. Cytyc's products cover a range of cancer and women's health applications, including cervical cancer screening, preterm birth screening, treatment of excessive menstrual bleeding, radiation treatment of early-stage breast cancer, and radiation treatment of patients with malignant brain tumors.


Related Links:
Hologic
Cytyc